PitchBook-生物技术和制药关税驱动的风险投资机会（英）-2025_7页_493kb

Biotech & Pharma Tariff-Driven Investment Opportunities Summary

Key Insights from PitchBook Report

The biotech sector is transitioning into an "America-first resurgence" phase, driven by protectionist tariff policies. This shift creates structural advantages for US-based companies but may temporarily impact merger and acquisition activity due to Big Pharma's focus on domestic manufacturing.

Tariff-Driven Effects and Opportunities

• Structural Advantages: Tariffs incentivize domestic production, accelerate AI-driven innovation, and enhance national security through advanced technologies.
• Investment Opportunities:
  • VC Focus: Prioritize AI platforms for drug discovery and regulatory compliance (e.g., Isomorphic Labs), and compact automation startups in manufacturing (e.g., Cellare, Cellino) to address efficiency needs amid higher labor costs.
  • PE Focus: Target infrastructure consolidation, high-value niches, and vertical integration in manufacturing, with potential for premium valuations amid reshoring trends.
• Market Dynamics: Tariff policies favor US-made pharmaceuticals, potentially leading to consolidation, competitive advantages for domestic products, and increased regulatory scrutiny on cross-border licensing, reducing reliance on foreign assets.

Evolution and Recommendations

• Three-Phase Biotech Evolution: From COVID-19 era influx to post-correction rationalization, now entering resilience phase with AI integration.
• Strategic Positioning: Early-stage investors should focus on algorithmic innovation and regulatory solutions; late-stage opportunities involve short-term returns through clinical or public market bets.
• Funding Shifts: Asia-based investment in US biotech declined sharply, with emerging roles for Middle Eastern sovereign funds, but risks include capital flight restrictions.

Outlook

Government interventions, similar to Operation Warp Speed, can dramatically transform the industry, emphasizing AI and manufacturing innovation for long-term success in a protectionist environment.